US Stem Cell (USRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5 | 30 | 10 | 15 | 39 |
| Receivables | 4 | 3 | 8 | 5 | 1 |
| Inventories | 1 | 1 | 1 | 1 | 0 |
| TOTAL | $68 | $172 | $71 | $142 | $51 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $68 | $172 | $71 | $142 | $51 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,398 | 1,398 | 1,398 | 1,398 | 1,398 |
| Accounts payable and accrued liabilities | 2,762 | 2,687 | 2,595 | 2,474 | 2,325 |
| Accrued Expenses | 2,583 | 2,411 | 2,251 | 2,103 | 1,951 |
| Other current liabilities | 468 | 468 | 468 | 468 | 468 |
| TOTAL | $14,078 | $13,628 | $13,173 | $12,742 | $12,039 |
| Non-Current Liabilities | |||||
| Long Term Debt | 682 | 692 | 702 | 712 | 722 |
| Other Non-Current Liabilities | 0 | 54 | 55 | 56 | 0 |
| TOTAL | $736 | $746 | $757 | $768 | $779 |
| Total Liabilities | $14,813 | $14,374 | $13,930 | $13,510 | $12,817 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 641,507 | 634,403 | 598,102 | 598,102 | 571,626 |
| Common Shares | 634 | 632 | 598 | 592 | 504 |
| Retained earnings | -142,517 | -141,951 | -141,385 | -140,815 | -139,802 |
| TOTAL | $-14,745 | $-14,202 | $-13,859 | $-13,367 | $-12,766 |
| Total Liabilities And Equity | $68 | $172 | $71 | $142 | $51 |